Results 21 to 30 of about 3,851 (159)
Journal of International Medical Research, 2022 Objective To conduct a meta-analysis to compare different dosing scalars of sugammadex in a morbidly obese population for reversal of neuromuscular blockade (NMB).
Jian-Qiang Liao +4 more
doaj +1 more source
Biological evaluation of the effect of sugammadex on hemostasis and bleeding [PDF]
Korean Journal of Anesthesiology, 2015 BackgroundNotification of sugammadex has been supplemented with a section on hemostasis, including a longer clotting time in the first minutes following injection, without any documented clinical consequences.
Julien Raft +4 more
doaj +1 more source
Rocuronium and Sugammadex Use Among Canadian Pediatric Anesthesiologists: A National Cross-Sectional Survey. [PDF]
Paediatr AnaesthPediatric Anesthesia, Volume 36, Issue 5, Page 567-570, May 2026.
Zhang M +3 more
europepmc +2 more sources
The Journal of Critical Care Medicine, 2016 Abstract The purpose of this update is to provide recent knowledge and debates regarding the use of sugammadex in the fields of anesthesia and critical care. The review is not intended to provide a comprehensive description of sugammadex and its clinical use.
Tiberiu, Ezri +4 more
openaire +2 more sources
Evaluation of the vasorelaxant effect of Sugammadex on the arterial smooth muscle in rats
Medicine Science, 2023 Although NMBAs (Neuro Muscular Blocking Agents) have been used for a long time, postoperative residual curarization is still a significant problem. Nowadays, an agent named Sugammadex is used for the reversal of curarization.
Mustafa Karademir +2 more
doaj +1 more source
Scientific Reports, 2022 Sugammadex has been approved for reversal of neuromuscular blockade by vecuronium and rocuronium in adults undergoing surgery. Although widely used in the operating room, sugammadex has not been investigated in the intensive care unit setting. This study
Răzvan Bologheanu +5 more
doaj +1 more source
Clinical and Translational Science, 2023 Sugammadex, a selective antagonist of steroidal non‐depolarizing neuromuscular blocking agents, has been used in children in limited circumstances. However, neither pharmacokinetics (PKs) nor recovery profile of sugammadex for intense neuromuscular ...
Sang‐Hwan Ji +8 more
doaj +1 more source
Frontiers in Pharmacology, 2023 Background: Sugammadex is known to reverse neuromuscular blockade induced by non-depolarizing agents. In children, the recommended dose for reversal of moderate neuromuscular blockade is 2 mg/kg.
Sang-Hwan Ji +17 more
doaj +1 more source
Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report- [PDF]
Korean Journal of Anesthesiology, 2019 Background Sugammadex is a reversal agent for non-depolarizing neuromuscular blockers and widely used worldwide on account of its rapid and effective reversal from neuromuscular blockade, despite its advantages, multiple cases of sugammadex-induced ...
Gunn Hee Kim +6 more
doaj +1 more source
Advantages and pitfalls of clinical application of sugammadex [PDF]
Anesthesia and Pain Medicine, 2020 Sugammadex, a modified γ-cyclodextrin, is one of the drugs focused on in the anesthetic field because it provides rapid and complete reversal from neuromuscular blockade (NMB) by encapsulating rocuronium.
Hyung Young Lee, Ki Tae Jung
doaj +1 more source